ArticleJACC. Case reports2025
Sternal Osteomyelitis Caused by Mycobacterium tuberculosis in a Heart Transplant Patient.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycobacterium tuberculosis (MT) infection poses a significant risk in immunocompromised individuals, particularly in areas with high MT prevalence. We describe the case of a 43-year-old heart transplant recipient who developed chronic sternal wound secretion post-transplant surgery. Imaging revealed signs of inflammatory tissue suggestive of chronic osteomyelitis. Removal of the sternal wires was performed, followed by biopsy, which identified granulomatous inflammatory tissue and Langhans cells, that led to the diagnosis of MT infection later confirmed in culture results. The patient completed a 6-month tetraconjugate antituberculous therapy, resulting in successful wound healing and infection resolution. Atypical extrapulmonary MT manifestations require high clinical suspicion, especially in immunocompromised patients, to ensure timely diagnosis and treatment with favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.